Market Research Report
Global Musculoskeletal Drugs Market 2011-2015
|Published by||TechNavio (Infiniti Research Ltd.)||Product code||242745|
|Published||Content info||37 Pages
|Global Musculoskeletal Drugs Market 2011-2015|
|Published: May 21, 2012||Content info: 37 Pages||
This publication has been discontinued on November 12, 2015.
TechNavio's analysts forecast the Global Musculoskeletal Drugs market to grow at a CAGR of 14.4 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing prevalence of musculoskeletal diseases. The Global Musculoskeletal Drugs market has also been witnessing the increasing use of drugs for treatment of multiple diseases. However, the upcoming patent expiries of top-selling drugs could pose a challenge to the growth of this market.
TechNavio's report, the Global Musculoskeletal Drugs Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Musculoskeletal Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Abbott Laboratories Inc., Eli Lilly and Co., Johnson and Johnson Services Inc., and Pfizer Inc.